This can be detected with SSTR-PET, in combination with 18F-FDG and PSMA-PET/CT, for a more comprehensive evaluation of tumour heterogeneity and underlying biology, which may not be apparent through PSA levels or PSMA-imaging alone [95]. The gene discussed is FOLH1; the disease is neoplasm.